
- On-demand
- About
This webinar will discuss Moody’s Ratings’ outlook for the global pharmaceutical industry over the next 12-18 months and key performance drivers. Among other positive trends, the pharmaceutical industry is benefiting from the rising use of GLP-1 drugs to treat obesity. The webinar will also discuss the potential impact of GLP-1 drugs on other industries.
- Positive outlook drivers for the global pharmaceutical industry
- Rising use of industry blockbusters including GLP-1 products
- Exposure to patent cliffs, quality of industry pipeline and rising use of biosimilars
- M&A activities and expectations
- Impact of GLP-1s on other sectors including medical devices, food/beverage and restaurants
-
Speakers
-
Event Manager
If you have any questions about the event, please contact Morgan Prokhin at morgan.prokhin@moodys.com.
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign In
Please sign in to your account: